Purpose Several studies evaluating stereotactic radiosurgery (SRS) for patients with> 4
brain metastases (BM) demonstrated similar outcomes after treatment of 1, 2 to 4, and 5 to …

The incidence of brain metastasis is increasing as improvements in systemic therapy lead to
increased survival. This provides new and challenging clinical decisions for patients who …

Introduction Brain metastasis velocity (BMV) is a prognostic metric that describes the
recurrence rate of new brain metastases after initial treatment with radiosurgery (SRS). We …

Purpose Breast cancer (BC) is the most frequently diagnosed tumor entity in women.
Occurring at different time intervals (TI) after BC diagnosis, brain metastases (BM) are …

Purpose This study, based on our brain metastasis (BM) patients undergoing stereotactic
radiosurgery (SRS) procedures, aimed to validate whether the recently-proposed prognostic …

Purpose This study aimed to validate whether the recently-proposed prognostic grading
system, initial brain metastasis velocity (iBMV), is applicable to breast cancer patients …

Purpose We investigated the prognostic ability of tumor subtype for patients with breast
cancer brain metastases (BCBM) treated with stereotactic radiation (SRT). Methods This is a …

Background Non-small cell lung cancer (NSCLC) is a prominent malignancy often linked to
the development of brain metastases (BM), which commonly appear at diverse time intervals …

Background Owing to the complexities of brain metastases (BMs), accurate and reliable
prognostic and predictive factors remain critical roadblocks in patients with lung …

Background and introduction Brain metastasis velocity (BMV) has been proposed as a
prognostic factor for overall survival (OS) in patients with brain metastases (BMs). In this …